Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.72 M1.82 M1.83 M2.48 M 7.86 M Research & development ———— — Operating income -1.84 M-126.7 M19.32 M22.79 M -86.43 M Non-Operating Income, Total 289 K-62.03 M338 K469 K -60.93 M Interest expense, net of interest capitalized 15.35 M14.6 M13.31 M12.54 M 55.81 M Non-Operating Income, excl. Interest Expenses -15.06 M-76.63 M-12.98 M-12.07 M -116.74 M Unusual income/expense ———— — Pretax income 8.29 M-53.04 M10.09 M12.44 M -22.21 M Equity in earnings ———— — Taxes 2.5 M-15.3 M3.14 M3.42 M -6.24 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 5.8 M-37.73 M6.95 M9.02 M -15.97 M Discontinued operations ———— — Net income 5.8 M-37.73 M6.95 M9.02 M -15.97 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 5.8 M-37.73 M6.95 M9.02 M -15.97 M Basic earnings per share (Basic EPS) 0.77-4.120.370.85 -2.13 Diluted earnings per share (Diluted EPS) 0.75-4.120.410.84 -2.12 Average basic shares outstanding 7.53 M9.17 M8.7 M10.6 M — Diluted shares outstanding 7.69 M9.17 M8.7 M10.77 M — EBITDA ———10.09 M — EBIT -1.82 M-127.01 M5.95 M10.06 M -112.83 M Cost of revenue 925 K1.35 M2.84 M1.45 M 6.56 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———31 K —